KCCure Announces New Chromophobe RCC Research Award

Learn More
Photo Credit: KCCure

Patient Voices



Latest Post

KCCure Announces New Research Grant For Chromophobe Renal Cell Carcinoma

November 19, 2021 KCCure is offering a grant totaling $50,000 for a project focused on innovative scientific research in chromophobe renal cell carcinoma (RCC)....Read More

Recent Posts

The Unanswered Question

The FDA approval of adjuvant Keytruda is a significant advancement in the treatment of renal cell carcinoma. Immune based adjuvant therapy provides an exciting ...Read More


Lost Password


Subscribe for updates!